GSK is expected to report earnings to fall 44.49% to 66 cents per share on July 27
Q2'22
Est.
$0.67
Q1'25
Beat
by $0.18
Q4'24
Missed
by $0.26
Q3'24
Beat
by $0.14
Q2'24
Beat
by $0.13
The last earnings report on April 30 showed earnings per share of $1.20, beating the estimate of $1.02. With 245.30K shares outstanding, the current market capitalization sits at 88.13B.